Clinical Trial Update: mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer Refractory to Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of mFOLFIRINOX with radiotherapy in CA19-9-normal advanced pancreatic cancer refractory to chemotherapy; statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• mFOLFIRINOX

Snippet

Sponsor: Fudan University | Conditions: Pancreatic Cancer, Radiotherapy | Phase 2 | Status: RECRUITING